India board revokes Roche hepatitis patent AFP The Intellectual Property Appellate Board overturned the patent awarded by the Indian Patent Office to Hoffmann-La Roche's drug Pegasys used to treat hepatitis C -- a disease that can lead to fatal liver problems. While Roche can still challenge the ... |
